Is ‘Right-to-try’ bill right?

Opinion |  Views | 0 Comment | 04 Jul, 2017

‘Right-to-try’ is being debated fiercely in US as the American Congress is considering a bill on the topic. It is a practice allowing patients diagnosed with terminal illnesses ...Read more

Stent Pricing: A right move

Opinion |  Views | 0 Comment | 19 May, 2017

Almost three months after the National Pharmaceutical Pricing Authority (NPPA) ceiling the maximum prices of cardiac stents, as expected, there have been complaints of non-compliance of the...Read more

Bionics potential largely untapped in India

Opinion |  Features | 1 Comment | 27 Apr, 2017

Artificial limbs that can help people walk, artificial eyes that help blind people see! Who knew that original body parts can be replaced by artificial ones. Welcome to the new world of bio...Read more

DermTech announces new pharma collaborations

Opinion |  News | By BioSpectrum Bureau | 0 Comment | 19 Apr, 2017

DermTech, Inc., the global leader in non-invasive molecular dermatology, has collaborated with two multi-national pharmaceutical companies. These two recent collaborations are further examp...Read more